GS-1160-180
GS-1160-180 is a PAF receptor antagonist. GS-1160-180 competes with PAF for receptor binding, with no activity against collagen or adenosine diphosphate-induced platelet aggregation. GS-1160-180 can be used for research on asthma, anaphylactic shock, gastric ulceration, and transplant rejection.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 111878-47-8
- Formule: C33H59BrN2O4S
- Masse moléculaire:659.80
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
GS-1160-180 (Compound 10) (100 nM; 3 min) competitively and specifically inhibits PAF-induced platelet aggregation in rabbit platelet-rich plasma, and shows no aggregation-inducing activity or off-target inhibition at concentrations ≤100 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
GS-1160-180 (0.5 mg/kg; i.v.; single dose) inhibits PAF-induced hypotension in rats, with an ED50 of 0.5 mg/kg i.v[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 111878-47-8
-
Masse moléculaire 659.80
-
Formule C33H59BrN2O4S
-
SMILES
O=C(NCCCCCCCCCCCCCCCCCC)OCC(COC(CCCCCC[N+]1=CSC=C1)=O)=C.[Br-]
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)